Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Hays (NPI 1801849690)

Field	Value
Entity Type	Individual
Organization	David Hays
Address	8901 Carti Way
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Vascular & Interventional Radiology Physician
NPI Enumerated	May 19, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider’s billed activity is concentrated squarely in Medicare: total Medicare revenue is $1.7M while there is none below — this provider has no Medicaid billing on file and is effectively a Medicare-focused practice. The top three Medicare codes account for 77.7% of total Medicare revenue, signaling a high revenue concentration in a narrow set of services.

The code mix and dollar concentration indicate a specialized nuclear medicine and image‑guided interventional practice. A9607 (Lutetium lu 177 vipivotide tetraxetan) generates $854.4K (50.5% of Medicare revenue) and 78815 (PET/CT) contributes $401.9K (23.7%), showing the business is built around radiopharmaceutical therapy paired with high PET/CT imaging throughput. A9596 (Gallium ga-68 gozetotide) also appears in the top three, reinforcing a focus on targeted diagnostic agents.

The revenue profile is highly concentrated: the precomputed top-3 share of 77.7% means a small set of radiopharmaceutical and PET/CT codes drive most receipts. That concentration suggests financial sensitivity to pricing, utilization, or coverage changes for A9607 and 78815 specifically, and highlights the importance of maintaining access to radiopharmaceutical supply chains and PET/CT capacity.

Competitive standing is mixed across the leading services. For PET/CT (78815) the provider ranks #404 of 6566 (94th percentile; notably above typical national volume), identifying the practice as a high-volume PET/CT performer nationally, whereas for A9607 the provider ranks #35 of 44 (21th percentile; typical, unremarkable volume for this code), indicating Lutetium therapy volume is modest relative to the small national cohort of high-volume therapy providers.

Several procedural codes mark the practice as more than imaging-only and indicate strong interventional support for delivering therapies. 36561 (central venous access devices) shows 74 claims and $34.2K revenue and ranks #30 of 3475 (99th percentile; extreme outlier), which is consistent with frequent placement/management of infusion or long-term access lines needed for radiopharmaceutical therapies. Additional image‑guided procedures and biopsies (for example, 32408, 47000, 49083) further demonstrate an interventional radiology capability alongside nuclear medicine services.

Multiple non-therapy imaging codes are also notable outliers in national comparisons, which reinforces the practice’s heavy imaging throughput. A9552 (FDG, 382 claims, $42.8K) ranks #105 of 2411 (96th percentile; notably above typical national volume) and 71260 (CT thorax with contrast, 354 claims, $27.3K) ranks #544 of 20343 (97th percentile; notably above typical national volume), indicating sustained, above-typical use of PET tracers and CT exams that support both diagnostic and treatment workflows.

The provider has long tenure in the Medicare program, with an NPI enumerated on 2006-05-19 (~20 years ago), suggesting established referral relationships and operational stability that likely support the specialized radiopharmaceutical and PET/CT services. This longevity may also reflect embedded infrastructure (scanners, access procedure capability, radiopharmacy arrangements) required to sustain the current service mix.

From a payer and contracting perspective, the absence of Medicaid billing combined with heavy reliance on a few high-revenue codes suggests concentrated reimbursement risk and negotiating leverage tied to Medicare volumes and specialty services. Payers and network managers should account for the provider’s national-level PET/CT strength and high central-line activity when evaluating credentialing, network inclusion, or reimbursement arrangements, because changes to coverage or reimbursement for A9607 or PET/CT could disproportionately affect this provider’s revenue base.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

57 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	4,210	$200	$854.4K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	380	$1,070	$401.9K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	80	$730	$59K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	270	$200	$53.4K
78816	The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The…	50	$1,080	$48.7K
A9587	Gallium ga-68, dotatate, diagnostic, 0.1 millicurie	230	$190	$44K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	380	$110	$42.8K
36561	A central venous access catheter is a device that the physician inserts beneath the skin to draw blood or administer medication/nutrients to the patient. The catheter's tip must terminate in the…	70	$460	$34.2K
71260	In this diagnostic procedure, the provider performs a computed tomography, or CT, examination of the thorax using contrast material.	350	$80	$27.3K
49083	In this procedure, the provider withdraws an abnormal buildup of fluid from the abdominal cavity to relieve pressure and pain or to obtain a sample to submit to a laboratory for analysis. He…	80	$200	$14.8K

Showing 1–10 of 57

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 57 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

David Hays — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

57 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9607	1	10	3,310	$200	$656.3K
A9596	7	10	80	$850	$87.3K
78815	11	100	90	$550	$83.7K
A9587	1	10	170	$200	$34.7K
A9552	8	40	180	$150	$28.9K
78816	12	40	30	$440	$25.8K
74177	28	210	120	$80	$12.3K
J3490	48	60	110	$70	$11.3K
36561	2	40	20	$410	$9.8K
74178	91	170	30	$120	$8.2K

Showing 1–10 of 57

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Hays, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M
Central Arkansas Radiation Therapy Institute Inc	AR	Radiation Oncology Physician	$6.7M	$3.6M
Kamal Patel	AR	Hematology & Oncology Physician	$5.7M	$0
Ryan Hall	AR	Hematology & Oncology Physician	$4.6M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Lawrence Mendelsohn	AR	Hematology & Oncology Physician	$3.4M	$0
Jamie Burton	AR	Hematology & Oncology Physician	$2.8M	$0
Kewen Jauss	AR	Hematology & Oncology Physician	$2.8M	$0
Mariann Harrington	AR	Hematology & Oncology Physician	$2.7M	$0
Appalanaidu Sasapu	AR	Hematology & Oncology Physician	$2.6M	$0

Nearby Providers

Other providers in the same ZIP code as David Hays, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Arkansas Department Of Health Std	AR	Public Health or Welfare Agency	$0	$8.4M

David Hays — Billing Profile & Reimbursement Data

Sign up for David Hays — Billing Profile & Reimbursement Data policy alerts

David Hays — Billing Profile & Reimbursement Data

Sign up for David Hays — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References